ALRN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Notice: This stock is marked as potentially delisted. It may not be actively trading.

Insider Ownership Percentage: 5.10%

Insider Buying (Last 12 Months): $896.00

Insider Selling (Last 12 Months): $0.00

Aileron Therapeutics Insider Trading History Chart

Aileron Therapeutics Share Price & Price History

^$0.00

+0.30 (1.20%)

As of 01/10/2025 05:00 PM ET

Aileron Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/5/2024	James Brian Windsor	CEO	Buy	400	$2.24	$896.00	239
6/17/2024	Of Texas/Texas Am I University	Major Shareholder	Sell	4,707	$3.25	$15,297.75	1,746,549
6/14/2024	Of Texas/Texas Am I University	Major Shareholder	Sell	1,900	$3.30	$6,270.00	1,751,256
6/12/2024	Of Texas/Texas Am I University	Major Shareholder	Sell	9,342	$3.25	$30,361.50	1,753,156
6/10/2024	Of Texas/Texas Am I University	Major Shareholder	Sell	9,577	$3.30	$31,604.10	1,768,250
6/7/2024	Of Texas/Texas Am I University	Major Shareholder	Sell	1,740	$3.26	$5,672.40	1,777,827
6/5/2024	Of Texas/Texas Am I University	Major Shareholder	Sell	6,291	$3.30	$20,760.30	1,783,851
5/1/2024	Of Texas/Texas Am I University	Major Shareholder	Sell	20,315	$4.21	$85,526.15	1,779,306
4/29/2024	Of Texas/Texas Am I University	Major Shareholder	Sell	10,746	$4.95	$53,192.70	1,799,711
12/15/2023	James Brian Windsor	COO	Buy	225	$3.37	$758.25	225
11/20/2023	James Brian Windsor	COO	Buy	5,076	$1.97	$9,999.72	5,122

See Full Table

SEC Filings (Institutional Ownership Changes) for Aileron Therapeutics (NASDAQ:ALRN)

90.89% of Aileron Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Aileron Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/16/2024	Geode Capital Management LLC	229,817	$0.81M	0.0%	+34.8%	1.061%
11/4/2024	Sigma Planning Corp	212,410	$0.75M	0.0%	+68.3%	0.980%
10/29/2024	KG&L Capital Management LLC	13,000	$46K	0.0%	N/A	0.060%
9/17/2024	University of Texas Texas AM Investment Management Co.	1,777,827	$4.93M	1.0%	N/A	8.225%
8/20/2024	Nantahala Capital Management LLC	464,367	$1.29M	0.1%	+82.1%	2.148%
8/9/2024	Renaissance Technologies LLC	24,864	$69K	0.0%	-44.8%	0.115%
8/9/2024	Warberg Asset Management LLC	31,354	$86K	0.0%	N/A	0.145%
8/2/2024	University of Texas Texas AM Investment Management Co.	1,777,827	$4.93M	1.9%	N/A	8.225%
5/13/2024	Texas Capital Bank Wealth Management Services Inc	26,171	$0.17M	0.0%	+65.9%	0.155%
2/8/2024	Texas Capital Bank Wealth Management Services Inc	15,773	$48K	0.0%	N/A	0.323%
2/1/2024	Sigma Planning Corp	16,580	$51K	0.0%	N/A	0.339%
2/15/2023	Alerce Investment Management L.P.	830,466	$1.97M	2.3%	-95.0%	18.288%
2/10/2023	Blair William & Co. IL	67,867	$0.16M	0.0%	-94.5%	1.495%
1/31/2023	KCK LTD.	22,341	$53K	0.1%	-95.0%	0.492%
10/31/2022	KCK LTD.	446,817	$0.10M	0.2%	-30.9%	0.492%
4/25/2022	Bailard Inc.	128,010	$66K	0.0%	N/A	0.141%
2/14/2022	Blair William & Co. IL	1,067,489	$0.60M	0.0%	+32.9%	1.179%
2/11/2022	KCK LTD.	646,817	$0.36M	0.3%	N/A	0.714%
2/10/2022	Acadian Asset Management LLC	85,274	$47K	0.0%	N/A	0.094%
2/4/2022	Envestnet Asset Management Inc.	136,760	$77K	0.0%	+152.4%	0.151%
2/2/2022	PVG Asset Management Corp	50,300	$28K	0.1%	+113.5%	0.056%
1/27/2022	Morgan Jess S & Co. Inc.	100,000	$56K	0.0%	+33.3%	0.110%
11/16/2021	Keebeck Wealth Management LLC	76,000	$78K	0.0%	-51.2%	0.084%
11/12/2021	Renaissance Technologies LLC	734,721	$0.75M	0.0%	-28.7%	0.811%
11/9/2021	Morgan Jess S & Co. Inc.	75,000	$76K	0.1%	N/A	0.083%
11/9/2021	Barclays PLC	25,279	$26K	0.0%	+235.4%	0.028%
11/9/2021	JFS Wealth Advisors LLC	31,807	$32K	0.0%	N/A	0.035%
10/26/2021	Game Plan Financial Advisors LLC	127,000	$0.13M	0.1%	+27.0%	0.140%
8/17/2021	Boothbay Fund Management LLC	393,015	$0.49M	0.0%	+11.8%	0.434%
8/16/2021	State Street Corp	71,200	$89K	0.0%	N/A	0.079%
8/13/2021	Renaissance Technologies LLC	1,031,128	$1.29M	0.0%	-17.5%	1.142%
8/13/2021	Geode Capital Management LLC	766,813	$0.96M	0.0%	+34.1%	0.849%
8/13/2021	Vanguard Group Inc.	3,440,633	$4.30M	0.0%	-5.9%	3.809%
8/12/2021	Blair William & Co. IL	688,044	$0.86M	0.0%	+99.1%	0.762%
8/4/2021	Envestnet Asset Management Inc.	34,654	$43K	0.0%	+45.1%	0.038%
5/21/2021	Citadel Advisors LLC	46,830	$67K	0.0%	N/A	0.052%
5/19/2021	Virtu Financial LLC	146,341	$0.21M	0.0%	+746.6%	0.162%
5/18/2021	BVF Inc. IL	5,265,555	$7.53M	0.3%	N/A	5.829%
5/18/2021	Citadel Advisors LLC	46,830	$67K	0.0%	N/A	0.052%
5/13/2021	Renaissance Technologies LLC	1,250,500	$1.79M	0.0%	+97.1%	1.385%
5/12/2021	Northern Trust Corp	127,883	$0.18M	0.0%	+378.0%	0.142%
5/12/2021	Geode Capital Management LLC	571,738	$0.82M	0.0%	+149.3%	0.633%

Data available starting January 2016

See Full Table

Aileron Therapeutics, Inc., a biopharmaceutical company, focuses on developing medicines to address unmet medical needs in orphan pulmonary and fibrosis indications in the United States. The company's lead product candidate is LTI-03, a peptide, which is in Phase 1b clinical trial for the treatment of idiopathic pulmonary fibrosis (IPF). Its second product candidate is LTI-01, a proenzyme that has completed Phase 1b and Phase 2a clinical trials in LPE patients for the treatment of loculated pleural effusion. The company's pipeline also includes preclinical programs targeting cystic fibrosis and a peptide program focused on the caveolin-1 protein for systemic fibrosis indications. The company was formerly known as Renegade Therapeutics, Inc. and changed its name to Aileron Therapeutics, Inc. in February 2007. Aileron Therapeutics, Inc. was incorporated in 2001 and is headquartered in Austin, Texas.

Today's Range

Now: N/A

50 Day Range

MA: $2.52

$1.75

$3.93

52 Week Range

Now: N/A

Volume

63,385 shs

Average Volume

81,188 shs

Market Capitalization

$45.72 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.24

Who are the company insiders with the largest holdings of Aileron Therapeutics?: Aileron Therapeutics' top insider shareholders include:
Of Texas/Texas Am I University (Major Shareholder)
James Brian Windsor (COO)
James Brian Windsor (CEO)
Learn More about top insider investors at Aileron Therapeutics.